2.0656
                                            Schlusskurs vom Vortag:
              $1.45
            Offen:
              $1.55
            24-Stunden-Volumen:
                14.19M
            Relative Volume:
              0.99
            Marktkapitalisierung:
                $98.89M
            Einnahmen:
              $1.20M
            Nettoeinkommen (Verlust:
              $-52.41M
            KGV:
              -2.2699
            EPS:
                -0.91
            Netto-Cashflow:
                $-31.25M
            1W Leistung:
              +15.38%
            1M Leistung:
              +320.17%
            6M Leistung:
                +89.19%
            1J Leistung:
              -8.30%
            Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
                  
                      Rani Therapeutics Holdings Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (408) 457-3700
                    
                Adresse
                  
                      2051 RINGWOOD AVENUE, SAN JOSE
                    
                Vergleichen Sie RANI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                RANI
                            
                             Rani Therapeutics Holdings Inc | 2.0998 | 141.43M | 1.20M | -52.41M | -31.25M | -0.91 | 
|   
                          
                                VRTX
                            
                             Vertex Pharmaceuticals Inc | 423.25 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 | 
|   
                          
                                REGN
                            
                             Regeneron Pharmaceuticals Inc | 649.59 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 | 
|   
                          
                                ALNY
                            
                             Alnylam Pharmaceuticals Inc | 453.28 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 | 
|   
                          
                                ARGX
                            
                             Argen X Se Adr | 807.96 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 | 
|   
                          
                                INSM
                            
                             Insmed Inc | 187.25 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 | 
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform | 
| 2024-06-14 | Eingeleitet | Maxim Group | Buy | 
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy | 
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy | 
| 2022-10-11 | Eingeleitet | UBS | Buy | 
| 2022-07-27 | Eingeleitet | H.C. Wainwright | Buy | 
| 2022-06-13 | Eingeleitet | Wedbush | Outperform | 
                    Alle ansehen
                     
                  
                Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
Multi asset correlation models including Rani Therapeutics Holdings Inc.2025 Stock Rankings & Low Drawdown Momentum Ideas - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthIPO Watch & Safe Capital Preservation Plans - newser.com
Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025Short Setup & Real-Time Volume Analysis Alerts - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.July 2025 Setups & Verified Momentum Stock Watchlist - newser.com
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times
Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan
Short interest data insights for Rani Therapeutics Holdings Inc.Stop Loss & Intraday High Probability Setup Alerts - newser.com
Can momentum traders help lift Rani Therapeutics Holdings Inc.Earnings Performance Report & Weekly Sector Rotation Insights - newser.com
Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - Nasdaq
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineOptions Play & AI Powered Market Entry Strategies - newser.com
Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat
Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo
Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey
Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener
Will Rani Therapeutics Holdings Inc. bounce back from current supportMarket Activity Report & Weekly Breakout Stock Alerts - newser.com
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis tools2025 Macro Impact & Daily Volume Surge Signals - newser.com
Rani Therapeutics director Imran Mir a buys $1.26 million in stock - Investing.com Philippines
Rani Therapeutics director Imran Mir a buys $1.26 million in stock By Investing.com - Investing.com South Africa
Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - TipRanks
Rani Therapeutics appoints new directors and closes private placement By Investing.com - Investing.com Nigeria
Rani Therapeutics appoints new directors and closes private placement - Investing.com
Rani Therapeutics Announces Board Changes - TradingView
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rani Therapeutics Holdings Inc-Aktie (RANI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt | 
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner | Oct 21 '25 | Sale | 2.77 | 4,000,000 | 11,074,000 | 2,379,194 | 
| South Cone Investments Limited | 10% Owner | Oct 20 '25 | Sale | 2.41 | 1,923,000 | 4,637,314 | 6,379,194 | 
| McKinley Kate | Chief Business Officer | Dec 13 '24 | Buy | 1.67 | 17,960 | 29,993 | 17,960 | 
| Imran Talat | Chief Executive Officer | Dec 09 '24 | Buy | 1.94 | 10,296 | 19,974 | 494,751 | 
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App